T Cell Redirecting Therapies for Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|16|1|22-33

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.1, 2016-01, pp. : 22-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer

By  

Current Drug Discovery Technologies, Vol. 6, Iss. 2, 2009-06 ,pp. : 91-102

Bentham Science Publishers

Access to resources Recommend Favorite

T Cell-based Therapies for Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5850-5858

Bentham Science Publishers

Access to resources Recommend Favorite

Bexarotene in combination with PUVA may be a treatment option in patients with cutaneous T-cell lymphoma refractory to multiple single-agent therapies

By  

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Novel Therapies for the Treatment of Small-Cell Lung Cancer: A Time for Cautious Optimism?

By Board Ruth E.   Thatcher Nick   Lorigan Paul  

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1919-1931

Adis International

Access to resources Recommend Favorite

Targeted therapies in small-cell lung cancer

By Fernainy Khaled   Saba Nabil  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 8, 2007-08 ,pp. : 1033-1041

Informa Healthcare

Access to resources Recommend Favorite